[18F]-29-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil ( 18F-FMAU) in prostate cancer: Initial preclinical observations

Hossein Jadvar, Li Peng Yap, Ryan Park, Zibo Li, Kai Chen, Lindsey Hughes, Aida Kouhi, Peter Conti

Research output: Contribution to journalArticle

  • 10 Citations

Abstract

We hypothesized that imaging-based assessment of cellular proliferation in prostate cancer may improve tumor characterization. We therefore evaluated the biodistribution and effect of androgen on tumor uptake of the cellular proliferation imaging marker [18F]-29- fluoro-5-methyl-1-beta-D- arabinofuranosyluracil (18F-FMAU) in xenograft mouse models of human prostate cancer. Castrated and noncastrated athymic male mice were implanted with androgen-independent PC3 and androgen-sensitive CWR22 human prostate cancer cells. Dynamic micro-positron emission tomography (PET)/computed tomography was performed for 1 hour followed by 10- minute static scans at 2 and 3 hours. Animals were sacrificed after imaging for biodistribution studies and immunohistochemical staining of tumors for androgen receptor and Ki-67/MIB expression. 18F-FMAU uptake was significantly higher in all major organs of the castrated animals in comparison with noncastrated mice, with the highest uptake in liver and the lowest uptake in muscle and bone. When compared to PC3 tumors, CWR22 xenografts showed significantly higher tumor to muscle (2.56 ± 0.30 vs 1.99 ± 0.30, p = .008) and tumor to liver (1.72 ± 0.12 vs 1.26 ± 0.17, p =.0003) uptake ratios in the noncastrated animal at the 3-hour time point. Androgen receptor and Ki-67/MIB expressions were higher in CWR22 than in PC3 xenografts. Our initial preclinical observations suggest that there may be an association between androgen signaling and thymidine metabolism and that 18F-FMAU PET may be useful in prostate tumor characterization.

LanguageEnglish (US)
Pages426-432
Number of pages7
JournalMolecular Imaging
Volume11
Issue number5
DOIs
StatePublished - Sep 1 2012
Externally publishedYes

Fingerprint

Arabinofuranosyluracil
Tumors
Prostatic Neoplasms
tumors
cancer
Androgens
Neoplasms
Heterografts
mice
animals
Animals
Positron emission tomography
tomography
Androgen Receptors
muscles
Imaging techniques
liver
Liver
Muscle
positrons

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Biomedical Engineering
  • Radiology Nuclear Medicine and imaging
  • Condensed Matter Physics

Cite this

[18F]-29-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil ( 18F-FMAU) in prostate cancer : Initial preclinical observations. / Jadvar, Hossein; Yap, Li Peng; Park, Ryan; Li, Zibo; Chen, Kai; Hughes, Lindsey; Kouhi, Aida; Conti, Peter.

In: Molecular Imaging, Vol. 11, No. 5, 01.09.2012, p. 426-432.

Research output: Contribution to journalArticle

Jadvar, H, Yap, LP, Park, R, Li, Z, Chen, K, Hughes, L, Kouhi, A & Conti, P 2012, '[18F]-29-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil ( 18F-FMAU) in prostate cancer: Initial preclinical observations' Molecular Imaging, vol. 11, no. 5, pp. 426-432. DOI: 10.2310/7290.2012.00004
Jadvar, Hossein ; Yap, Li Peng ; Park, Ryan ; Li, Zibo ; Chen, Kai ; Hughes, Lindsey ; Kouhi, Aida ; Conti, Peter. / [18F]-29-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil ( 18F-FMAU) in prostate cancer : Initial preclinical observations. In: Molecular Imaging. 2012 ; Vol. 11, No. 5. pp. 426-432
@article{ec49c7fa30bc4adc8de4cd3703d16703,
title = "[18F]-29-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil ( 18F-FMAU) in prostate cancer: Initial preclinical observations",
abstract = "We hypothesized that imaging-based assessment of cellular proliferation in prostate cancer may improve tumor characterization. We therefore evaluated the biodistribution and effect of androgen on tumor uptake of the cellular proliferation imaging marker [18F]-29- fluoro-5-methyl-1-beta-D- arabinofuranosyluracil (18F-FMAU) in xenograft mouse models of human prostate cancer. Castrated and noncastrated athymic male mice were implanted with androgen-independent PC3 and androgen-sensitive CWR22 human prostate cancer cells. Dynamic micro-positron emission tomography (PET)/computed tomography was performed for 1 hour followed by 10- minute static scans at 2 and 3 hours. Animals were sacrificed after imaging for biodistribution studies and immunohistochemical staining of tumors for androgen receptor and Ki-67/MIB expression. 18F-FMAU uptake was significantly higher in all major organs of the castrated animals in comparison with noncastrated mice, with the highest uptake in liver and the lowest uptake in muscle and bone. When compared to PC3 tumors, CWR22 xenografts showed significantly higher tumor to muscle (2.56 ± 0.30 vs 1.99 ± 0.30, p = .008) and tumor to liver (1.72 ± 0.12 vs 1.26 ± 0.17, p =.0003) uptake ratios in the noncastrated animal at the 3-hour time point. Androgen receptor and Ki-67/MIB expressions were higher in CWR22 than in PC3 xenografts. Our initial preclinical observations suggest that there may be an association between androgen signaling and thymidine metabolism and that 18F-FMAU PET may be useful in prostate tumor characterization.",
author = "Hossein Jadvar and Yap, {Li Peng} and Ryan Park and Zibo Li and Kai Chen and Lindsey Hughes and Aida Kouhi and Peter Conti",
year = "2012",
month = "9",
day = "1",
doi = "10.2310/7290.2012.00004",
language = "English (US)",
volume = "11",
pages = "426--432",
journal = "Molecular Imaging",
issn = "1535-3508",
publisher = "Decker Publishing",
number = "5",

}

TY - JOUR

T1 - [18F]-29-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil ( 18F-FMAU) in prostate cancer

T2 - Molecular Imaging

AU - Jadvar,Hossein

AU - Yap,Li Peng

AU - Park,Ryan

AU - Li,Zibo

AU - Chen,Kai

AU - Hughes,Lindsey

AU - Kouhi,Aida

AU - Conti,Peter

PY - 2012/9/1

Y1 - 2012/9/1

N2 - We hypothesized that imaging-based assessment of cellular proliferation in prostate cancer may improve tumor characterization. We therefore evaluated the biodistribution and effect of androgen on tumor uptake of the cellular proliferation imaging marker [18F]-29- fluoro-5-methyl-1-beta-D- arabinofuranosyluracil (18F-FMAU) in xenograft mouse models of human prostate cancer. Castrated and noncastrated athymic male mice were implanted with androgen-independent PC3 and androgen-sensitive CWR22 human prostate cancer cells. Dynamic micro-positron emission tomography (PET)/computed tomography was performed for 1 hour followed by 10- minute static scans at 2 and 3 hours. Animals were sacrificed after imaging for biodistribution studies and immunohistochemical staining of tumors for androgen receptor and Ki-67/MIB expression. 18F-FMAU uptake was significantly higher in all major organs of the castrated animals in comparison with noncastrated mice, with the highest uptake in liver and the lowest uptake in muscle and bone. When compared to PC3 tumors, CWR22 xenografts showed significantly higher tumor to muscle (2.56 ± 0.30 vs 1.99 ± 0.30, p = .008) and tumor to liver (1.72 ± 0.12 vs 1.26 ± 0.17, p =.0003) uptake ratios in the noncastrated animal at the 3-hour time point. Androgen receptor and Ki-67/MIB expressions were higher in CWR22 than in PC3 xenografts. Our initial preclinical observations suggest that there may be an association between androgen signaling and thymidine metabolism and that 18F-FMAU PET may be useful in prostate tumor characterization.

AB - We hypothesized that imaging-based assessment of cellular proliferation in prostate cancer may improve tumor characterization. We therefore evaluated the biodistribution and effect of androgen on tumor uptake of the cellular proliferation imaging marker [18F]-29- fluoro-5-methyl-1-beta-D- arabinofuranosyluracil (18F-FMAU) in xenograft mouse models of human prostate cancer. Castrated and noncastrated athymic male mice were implanted with androgen-independent PC3 and androgen-sensitive CWR22 human prostate cancer cells. Dynamic micro-positron emission tomography (PET)/computed tomography was performed for 1 hour followed by 10- minute static scans at 2 and 3 hours. Animals were sacrificed after imaging for biodistribution studies and immunohistochemical staining of tumors for androgen receptor and Ki-67/MIB expression. 18F-FMAU uptake was significantly higher in all major organs of the castrated animals in comparison with noncastrated mice, with the highest uptake in liver and the lowest uptake in muscle and bone. When compared to PC3 tumors, CWR22 xenografts showed significantly higher tumor to muscle (2.56 ± 0.30 vs 1.99 ± 0.30, p = .008) and tumor to liver (1.72 ± 0.12 vs 1.26 ± 0.17, p =.0003) uptake ratios in the noncastrated animal at the 3-hour time point. Androgen receptor and Ki-67/MIB expressions were higher in CWR22 than in PC3 xenografts. Our initial preclinical observations suggest that there may be an association between androgen signaling and thymidine metabolism and that 18F-FMAU PET may be useful in prostate tumor characterization.

UR - http://www.scopus.com/inward/record.url?scp=84870976337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870976337&partnerID=8YFLogxK

U2 - 10.2310/7290.2012.00004

DO - 10.2310/7290.2012.00004

M3 - Article

VL - 11

SP - 426

EP - 432

JO - Molecular Imaging

JF - Molecular Imaging

SN - 1535-3508

IS - 5

ER -